The effects of favipiravir on hematological parameters of covıd-19 patients.

Selcuk Yaylacı Hamad Dheir Didar Senocak Ahmed Bilal Genc Havva Kocayigit Deniz Çekiç Ceyhun Varim Abdülkadir Aydın Mehmet Ramazan Şekeroğlu Yasemin Gündüz

Published in: Revista da Associacao Medica Brasileira (1992) (2020)

We concluded that the pathological effect of treatment with favipiravir on the hematologic system was the suppression in the erythrocyte series, and there were no adverse effects in other hematologic parameters.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
sars cov
peritoneal dialysis
prognostic factors
respiratory syndrome coronavirus
combination therapy